Cargando…

The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission

OBJECTIVE: Airborne infection from aerosolized SARS-CoV-2 poses an economic challenge for businesses without existing heating, ventilation, and air conditioning (HVAC) systems. The Environmental Protection Agency notes that standalone units may be used in areas without existing HVAC systems, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafari, Zafar, de Oliveira, Pedro M., Gkantonas, Savvas, Ezeh, Chinenye, Muennig, Peter Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096756/
https://www.ncbi.nlm.nih.gov/pubmed/35549719
http://dx.doi.org/10.1186/s12962-022-00356-1
_version_ 1784706047266521088
author Zafari, Zafar
de Oliveira, Pedro M.
Gkantonas, Savvas
Ezeh, Chinenye
Muennig, Peter Alexander
author_facet Zafari, Zafar
de Oliveira, Pedro M.
Gkantonas, Savvas
Ezeh, Chinenye
Muennig, Peter Alexander
author_sort Zafari, Zafar
collection PubMed
description OBJECTIVE: Airborne infection from aerosolized SARS-CoV-2 poses an economic challenge for businesses without existing heating, ventilation, and air conditioning (HVAC) systems. The Environmental Protection Agency notes that standalone units may be used in areas without existing HVAC systems, but the cost and effectiveness of standalone units has not been evaluated. STUDY DESIGN: Cost-effectiveness analysis with Monte Carlo simulation and aerosol transmission modeling. METHODS: We built a probabilistic decision-analytic model in a Monte Carlo simulation that examines aerosol transmission of SARS-CoV-2 in an indoor space. As a base case study, we built a model that simulated a poorly ventilated indoor 1000 square foot restaurant and the range of Covid-19 prevalence of actively infectious cases (best-case: 0.1%, base-case: 2%, and worst-case: 3%) and vaccination rates (best-case: 90%, base-case: 70%, and worst-case: 0%) in New York City. We evaluated the cost-effectiveness of improving ventilation rate to 12 air changes per hour (ACH), the equivalent of hospital-grade filtration systems used in emergency departments. We also provide a customizable online tool that allows the user to change model parameters. RESULTS: All 3 scenarios resulted in a net cost-savings and infections averted. For the base-case scenario, improving ventilation to 12 ACH was associated with 54 [95% Credible Interval (CrI): 29–86] aerosol infections averted over 1 year, producing an estimated cost savings of $152,701 (95% CrI: $80,663, $249,501) and 1.35 (95% CrI: 0.72, 2.24) quality-adjusted life years (QALYs) gained. CONCLUSIONS: It is cost-effective to improve indoor ventilation in small businesses in older buildings that lack HVAC systems during the pandemic.
format Online
Article
Text
id pubmed-9096756
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90967562022-05-12 The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission Zafari, Zafar de Oliveira, Pedro M. Gkantonas, Savvas Ezeh, Chinenye Muennig, Peter Alexander Cost Eff Resour Alloc Research OBJECTIVE: Airborne infection from aerosolized SARS-CoV-2 poses an economic challenge for businesses without existing heating, ventilation, and air conditioning (HVAC) systems. The Environmental Protection Agency notes that standalone units may be used in areas without existing HVAC systems, but the cost and effectiveness of standalone units has not been evaluated. STUDY DESIGN: Cost-effectiveness analysis with Monte Carlo simulation and aerosol transmission modeling. METHODS: We built a probabilistic decision-analytic model in a Monte Carlo simulation that examines aerosol transmission of SARS-CoV-2 in an indoor space. As a base case study, we built a model that simulated a poorly ventilated indoor 1000 square foot restaurant and the range of Covid-19 prevalence of actively infectious cases (best-case: 0.1%, base-case: 2%, and worst-case: 3%) and vaccination rates (best-case: 90%, base-case: 70%, and worst-case: 0%) in New York City. We evaluated the cost-effectiveness of improving ventilation rate to 12 air changes per hour (ACH), the equivalent of hospital-grade filtration systems used in emergency departments. We also provide a customizable online tool that allows the user to change model parameters. RESULTS: All 3 scenarios resulted in a net cost-savings and infections averted. For the base-case scenario, improving ventilation to 12 ACH was associated with 54 [95% Credible Interval (CrI): 29–86] aerosol infections averted over 1 year, producing an estimated cost savings of $152,701 (95% CrI: $80,663, $249,501) and 1.35 (95% CrI: 0.72, 2.24) quality-adjusted life years (QALYs) gained. CONCLUSIONS: It is cost-effective to improve indoor ventilation in small businesses in older buildings that lack HVAC systems during the pandemic. BioMed Central 2022-05-12 /pmc/articles/PMC9096756/ /pubmed/35549719 http://dx.doi.org/10.1186/s12962-022-00356-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zafari, Zafar
de Oliveira, Pedro M.
Gkantonas, Savvas
Ezeh, Chinenye
Muennig, Peter Alexander
The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title_full The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title_fullStr The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title_full_unstemmed The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title_short The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission
title_sort cost-effectiveness of standalone hepa filtration units for the prevention of airborne sars cov-2 transmission
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096756/
https://www.ncbi.nlm.nih.gov/pubmed/35549719
http://dx.doi.org/10.1186/s12962-022-00356-1
work_keys_str_mv AT zafarizafar thecosteffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT deoliveirapedrom thecosteffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT gkantonassavvas thecosteffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT ezehchinenye thecosteffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT muennigpeteralexander thecosteffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT zafarizafar costeffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT deoliveirapedrom costeffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT gkantonassavvas costeffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT ezehchinenye costeffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission
AT muennigpeteralexander costeffectivenessofstandalonehepafiltrationunitsforthepreventionofairbornesarscov2transmission